Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 4
1990 1
1994 2
1996 2
1997 1
1998 3
1999 1
2000 2
2001 2
2002 1
2005 1
2006 5
2007 2
2008 2
2009 5
2010 1
2011 2
2012 3
2013 2
2014 1
2015 1
2016 4
2017 3
2018 2
2019 1
2020 3
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Results by year
Filters applied: . Clear all
Page 1
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
McElvaney NG, Burdon J, Holmes M, Glanville A, Wark PA, Thompson PJ, Hernandez P, Chlumsky J, Teschler H, Ficker JH, Seersholm N, Altraja A, Mäkitaro R, Chorostowska-Wynimko J, Sanak M, Stoicescu PI, Piitulainen E, Vit O, Wencker M, Tortorici MA, Fries M, Edelman JM, Chapman KR; RAPID Extension Trial Group. McElvaney NG, et al. Among authors: wencker m. Lancet Respir Med. 2017 Jan;5(1):51-60. doi: 10.1016/S2213-2600(16)30430-1. Epub 2016 Dec 2. Lancet Respir Med. 2017. PMID: 27916480 Clinical Trial.
Zeb1 represses TCR signaling, promotes the proliferation of T cell progenitors and is essential for NK1.1+ T cell development.
Zhang J, Wencker M, Marliac Q, Berton A, Hasan U, Schneider R, Laubreton D, Cherrier DE, Mathieu AL, Rey A, Jiang W, Caramel J, Genestier L, Marçais A, Marvel J, Ghavi-Helm Y, Walzer T. Zhang J, et al. Among authors: wencker m. Cell Mol Immunol. 2020 May 12. doi: 10.1038/s41423-020-0459-y. Online ahead of print. Cell Mol Immunol. 2020. PMID: 32398809
Clinical considerations in individuals with α1-antitrypsin PI*SZ genotype.
McElvaney GN, Sandhaus RA, Miravitlles M, Turino GM, Seersholm N, Wencker M, Stockley RA. McElvaney GN, et al. Among authors: wencker m. Eur Respir J. 2020 Jun 18;55(6):1902410. doi: 10.1183/13993003.02410-2019. Print 2020 Jun. Eur Respir J. 2020. PMID: 32165400 Free PMC article. Review.
Safety of biweekly α1-antitrypsin treatment in the RAPID programme.
Greulich T, Chlumsky J, Wencker M, Vit O, Fries M, Chung T, Shebl A, Vogelmeier C, Chapman KR, McElvaney NG; RAPID Trial Group. Greulich T, et al. Among authors: wencker m. Eur Respir J. 2018 Nov 29;52(5):1800897. doi: 10.1183/13993003.00897-2018. Print 2018 Nov. Eur Respir J. 2018. PMID: 30237305 Free PMC article. Clinical Trial.
[Rare diseases in pulmonary medicine and its challenges].
Wencker M, Teschler H, Vogelmeier C, Koczulla R. Wencker M, et al. Pneumologie. 2012 Jul;66(7):437-41. doi: 10.1055/s-0032-1309876. Epub 2012 Jun 12. Pneumologie. 2012. PMID: 22692970 Free article. Review. German.
Immune signatures of protective spleen memory CD8 T cells.
Brinza L, Djebali S, Tomkowiak M, Mafille J, Loiseau C, Jouve PE, de Bernard S, Buffat L, Lina B, Ottmann M, Rosa-Calatrava M, Schicklin S, Bonnefoy N, Lauvau G, Grau M, Wencker M, Arpin C, Walzer T, Leverrier Y, Marvel J. Brinza L, et al. Among authors: wencker m. Sci Rep. 2016 Nov 24;6:37651. doi: 10.1038/srep37651. Sci Rep. 2016. PMID: 27883012 Free PMC article.
57 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page